Aranthan Jones II, Chief Corporate Affairs Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 33,648 shares at $16.49 ($555K) on 2021-09-15, disclosed to the SEC on 2021-09-17.
Open-market sale of $555k VNDA by Chief Corporate Affairs Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.49 | 16,824 | $277K | 50.0% |
| 2 | $16.49 | 16,824 | $277K | 50.0% |
| Total | $16.49 avg | 33,648 | $555K | 100% |
| Filing → |
| VNDA | SELL | 2021-03-03 | $139K | — | Filing → |
| VNDA | SELL | 2021-02-26 | $920K | — | Filing → |
| VNDA | SELL | 2020-08-14 | $85K | — | Filing → |